Ionis Partners with Sobi for Olezarsen to Treat Familial Chylomicronemia Syndrome (FCS) & Severely Elevated Triglycerides
Shots: Ionis has granted Sobi global exclusive rights of olezarsen excl. the US, C...
Bayer Enters Global License Agreement with Suzhou Puhe BioPharma for its PRMT5 Inhibitor
Shots: Bayer & Suzhou Puhe BioPharma have entered into a global license agreem...
Merck Partners with Jiangsu Hengrui Pharmaceuticals for HRS-5346, Expanding its Cardio-Metabolic Portfolio
Shots: Merck has entered into an exclusive license agreement with Jiangsu Hengrui...
Alumis and Kaken Pharmaceutical Enter Collaboration & Licencing Deal for ESK-001’s Development & Commercialization in Japan
Shots: Alumis & Kaken have partnered to develop, manufacture, & market ESK...
The United Laboratories (TUL) and Novo Nordisk Enter Exclusive License Agreement for UBT251
Shots: TUL has granted Novo Nordisk exclusive global rights to develop, manufactur...
Harbour BioMed & AstraZeneca Partner to Develop Multi-Specific Antibodies across Various Therapeutic Areas
Shots: Harbour & AstraZeneca (AZ) have entered into a global strategic collabo...
